The Global Diabetes Care Devices & Drugs Market will grow at a CAGR of 5.2% from 2017 to 2022 to reach USD 85,591.2 million by 2022, according to this latest publication from Meticulous Research®.

The global diabetes care devices & drugs market is driven by the increasing incidence & prevalence of diabetes, various technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. In addition, development of new formulations and insulin delivery technologies further provides significant opportunities for the various stakeholders in this market. However, high cost associated with diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of this market to some extent.
Browse In-depth report on: https://www.meticulousresearch.com/product/diabetes-care-devices-market-2022/
The global diabetes care devices & drugs market is mainly segmented by different type of devices and drugs. Diabetes care drugs segment dominated the overall market in 2016, and is expected to continue its dominance during the forecast period. The large share of this market is attributed to the huge demand for insulin and oral hypoglycemic drugs for the treatment of type I & II diabetes.
The diabetes care drugs market is categorized into insulin, oral hypoglycaemic drugs, and non-insulin injectable drugs. Insulin held the largest share in the global diabetes care drugs market in 2016. The largest share of this market is mainly attributed to the increasing use of insulin to control the glucose level in blood by type 1 diabetes patients, rising market demand for human insulin analogs, and favorable medical reimbursements.
Scope of the Report
Market by Type
• Diabetes monitoring devices
• Test strips
• Self-monitoring devices
• Continuous blood glucose monitoring devices
• Lancets
• Hemoglobin A1c testing kits
• Insulin delivery devices
• Insulin Pens
• Insulin Syringes
• Insulin Pumps
• Insulin Jet Injectors
Market by Geography
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Rest of Asia-Pacific
• Rest of World
• Latin America
• Middle East and Africa
The leading players in diabetes care devices & drugs market have employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in this market were partnerships/collaborations/agreements, new product launches, and expansions. The key players in the global diabetes care devices & drugs market are Novo Nordisk A/S, Ypsomed AG, Abbott, Ascensia Diabetes Care Holdings AG, Eli Lilly and Company, Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, Sanofi S.A., Merck & Co., Inc.,Novartis AG, AstraZeneca PLC, and Boehringer Ingelheim GmbH.
Download Sample Report On: https://www.meticulousresearch.com/download-sample-report/?cp_id=3305

Contact us :
khushal
Meticulous Research®
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)